Cargando…
Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis
BACKGROUND: To perform a meta-analysis evaluating the diagnostic ability of fecal lactoferrin (FL) to distinguish inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS). METHODS: The Medline, EMBASE, Web of Science, Cochrane library and CNKI databases were systematically searched for s...
Autores principales: | Zhou, Xing-lu, Xu, Wen, Tang, Xiao-xiao, Luo, Lai-sheng, Tu, Jiang-feng, Zhang, Chen-jing, Xu, Xiang, Wu, Qin-dong, Pan, Wen-sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105129/ https://www.ncbi.nlm.nih.gov/pubmed/25002150 http://dx.doi.org/10.1186/1471-230X-14-121 |
Ejemplares similares
-
Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019) -
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021) -
Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019) -
The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021) -
Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts
Therapeutic Response in Inflammatory Bowel Disease
por: Sorrentino, Dario, et al.
Publicado: (2021)